Literature DB >> 18799577

Measles viruses possessing the polymerase protein genes of the Edmonston vaccine strain exhibit attenuated gene expression and growth in cultured cells and SLAM knock-in mice.

Makoto Takeda1, Shinji Ohno, Maino Tahara, Hiroki Takeuchi, Yuta Shirogane, Hirofumi Ohmura, Takafumi Nakamura, Yusuke Yanagi.   

Abstract

Live attenuated vaccines against measles have been developed through adaptation of clinical isolates of measles virus (MV) in various cultured cells. Analyses using recombinant MVs with chimeric genomes between wild-type and Edmonston vaccine strains indicated that viruses possessing the polymerase protein genes of the Edmonston strain exhibited attenuated viral gene expression and growth in cultured cells as well as in mice expressing an MV receptor, signaling lymphocyte activation molecule, regardless of whether the virus genome had the wild-type or vaccine-type promoter sequence. These data demonstrate that the polymerase protein genes of the Edmonston strain contribute to its attenuated phenotype.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799577      PMCID: PMC2583675          DOI: 10.1128/JVI.00867-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides.

Authors:  C D Richardson; A Scheid; P W Choppin
Journal:  Virology       Date:  1980-08       Impact factor: 3.616

2.  SLAM (CDw150) is a cellular receptor for measles virus.

Authors:  H Tatsuo; N Ono; K Tanaka; Y Yanagi
Journal:  Nature       Date:  2000-08-24       Impact factor: 49.962

3.  Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus.

Authors:  F Kobune; H Sakata; A Sugiura
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

4.  Analysis of receptor (CD46, CD150) usage by measles virus.

Authors:  Christian Erlenhöfer; W Paul Duprex; Bert K Rima; Volker Ter Meulen; Jürgen Schneider-Schaulies
Journal:  J Gen Virol       Date:  2002-06       Impact factor: 3.891

5.  Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor.

Authors:  N Ono; H Tatsuo; Y Hidaka; T Aoki; H Minagawa; Y Yanagi
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction.

Authors:  Shinji Ohno; Nobuyuki Ono; Makoto Takeda; Kaoru Takeuchi; Yusuke Yanagi
Journal:  J Gen Virol       Date:  2004-10       Impact factor: 3.891

7.  Activity of polymerase proteins of vaccine and wild-type measles virus strains in a minigenome replication assay.

Authors:  Bettina Bankamp; Sean P Kearney; Xin Liu; William J Bellini; Paul A Rota
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein.

Authors:  Koji Hashimoto; Nobuyuki Ono; Hironobu Tatsuo; Hiroko Minagawa; Makoto Takeda; Kaoru Takeuchi; Yusuke Yanagi
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

9.  Altered ratios of measles virus transcripts in diseased human brains.

Authors:  R Cattaneo; G Rebmann; K Baczko; V ter Meulen; M A Billeter
Journal:  Virology       Date:  1987-10       Impact factor: 3.616

10.  Altered transcription of a defective measles virus genome derived from a diseased human brain.

Authors:  R Cattaneo; G Rebmann; A Schmid; K Baczko; V ter Meulen; M A Billeter
Journal:  EMBO J       Date:  1987-03       Impact factor: 11.598

View more
  19 in total

1.  A highly attenuated measles virus vaccine strain encodes a fully functional C protein.

Authors:  Yuichiro Nakatsu; Makoto Takeda; Masaharu Iwasaki; Yusuke Yanagi
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

Review 2.  Measles Vaccine.

Authors:  Diane E Griffin
Journal:  Viral Immunol       Date:  2017-12-19       Impact factor: 2.257

3.  The SI strain of measles virus derived from a patient with subacute sclerosing panencephalitis possesses typical genome alterations and unique amino acid changes that modulate receptor specificity and reduce membrane fusion activity.

Authors:  Fumio Seki; Kentaro Yamada; Yuichiro Nakatsu; Koji Okamura; Yusuke Yanagi; Tetsuo Nakayama; Katsuhiro Komase; Makoto Takeda
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

4.  Annexin A2 Mediates the Localization of Measles Virus Matrix Protein at the Plasma Membrane.

Authors:  Ritsuko Koga; Marie Kubota; Takao Hashiguchi; Yusuke Yanagi; Shinji Ohno
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

5.  Measles virus mutants possessing the fusion protein with enhanced fusion activity spread effectively in neuronal cells, but not in other cells, without causing strong cytopathology.

Authors:  Shumpei Watanabe; Shinji Ohno; Yuta Shirogane; Satoshi O Suzuki; Ritsuko Koga; Yusuke Yanagi
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

6.  Wild-type measles virus with the hemagglutinin protein of the edmonston vaccine strain retains wild-type tropism in macaques.

Authors:  Kaoru Takeuchi; Noriyo Nagata; Sei-Ich Kato; Yasushi Ami; Yuriko Suzaki; Tadaki Suzuki; Yuko Sato; Yasuko Tsunetsugu-Yokota; Kazuyasu Mori; Nguyen Van Nguyen; Hideki Kimura; Kyosuke Nagata
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

7.  Enhanced antitumor effects of an engineered measles virus Edmonston strain expressing the wild-type N, P, L genes on human renal cell carcinoma.

Authors:  Xin Meng; Takafumi Nakamura; Toshihiko Okazaki; Hiroyuki Inoue; Atsushi Takahashi; Shohei Miyamoto; Gaku Sakaguchi; Masatoshi Eto; Seiji Naito; Makoto Takeda; Yusuke Yanagi; Kenzaburo Tani
Journal:  Mol Ther       Date:  2010-01-05       Impact factor: 11.454

8.  The receptor-binding site of the measles virus hemagglutinin protein itself constitutes a conserved neutralizing epitope.

Authors:  Maino Tahara; Shinji Ohno; Kouji Sakai; Yuri Ito; Hideo Fukuhara; Katsuhiro Komase; Melinda A Brindley; Paul A Rota; Richard K Plemper; Katsumi Maenaka; Makoto Takeda
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

9.  The matrix protein of measles virus regulates viral RNA synthesis and assembly by interacting with the nucleocapsid protein.

Authors:  Masaharu Iwasaki; Makoto Takeda; Yuta Shirogane; Yuichiro Nakatsu; Takanori Nakamura; Yusuke Yanagi
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

10.  Intracellular transport of the measles virus ribonucleoprotein complex is mediated by Rab11A-positive recycling endosomes and drives virus release from the apical membrane of polarized epithelial cells.

Authors:  Yuichiro Nakatsu; Xuemin Ma; Fumio Seki; Tadaki Suzuki; Masaharu Iwasaki; Yusuke Yanagi; Katsuhiro Komase; Makoto Takeda
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.